Latest News for: gpcr
Edit
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company
Nasdaq Globe Newswire 12 Feb 2026
... Nxera’s G protein-coupled receptor (GPCR)-targeted program (the “Program”).
Edit
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company (Nxera Pharma Co Ltd)
Public Technologies 12 Feb 2026
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company ... sciences investment firm, to advance Nxera's G protein-coupled receptor (GPCR)-targeted program (the "Program").
Edit
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
Pharmiweb 13 Jan 2026
Edit
Amerigo Scientific Launches Reliable GPCR Phosphorylation Immunoassay Kits to Accelerate Drug Discovery and Biomedical Research
GetNews 30 Dec 2025
Amerigo Scientific announced the availability of its expanded line of GPCR phosphorylation immunoassay kits, designed for the quantitative detection of G protein-coupled receptor (GPCR) phosphorylation.
Edit
Structural findings reveal how distinct GPCR ligands create different levels of activation
Phys Dot Org 22 Dec 2025
....
Edit
Structure Therapeutics stock: what’s driving sudden 103% jump in GPCR shares?
Invezz 08 Dec 2025
Edit
The far extracellular CUB domain of the adhesion GPCR ADGRG6/GPR126 is a key regulator of ...
PNAS 26 Nov 2025
Our ... .
Edit
BioAscent and Keltic Pharma Therapeutics partner to give customers access to cutting-edge peptide discovery platform for GPCR targets
Pharmiweb 19 Nov 2025
Collaboration set to enhance peptide discovery for challenging GPCR targets and advancing research across multiple therapeutic areas. ... ... ... ... ... ... ... .
Edit
Final Trade: BCS, XBI, BIDU, GPCR
CNBC 18 Nov 2025
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders ... .
Edit
Final Trade: UBER, CRWV, GPCR, DIS
CNBC 10 Nov 2025
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders ... .
- 1